The Technical Analyst
Select Language :
Allied Corp. [ALID]

Exchange: PNK Industry: Drug Manufacturers

Allied Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Allied Corp. is listed at the  Exchange

-14.10% $0.145

America/New_York / 3 mai 2024 @ 15:52


FUNDAMENTALS
MarketCap: 15.34 mill
EPS: -0.100
P/E: -1.450
Earnings Date: N/A
SharesOutstanding: 105.82 mill
Avg Daily Volume: 0.0154 mill
RATING 2024-05-03
C
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.450 | sector: PE -11.58
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -1.450 | industry: PE -6.21
DISCOUNTED CASH FLOW VALUE
$-0.0728
(-150.18%) $-0.218
Date: 2024-05-04
Expected Trading Range (DAY)

$ 0.114 - 0.176

( +/- 21.38%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-04-27 Robinson James George Buy 40 000 Common Stock
2023-04-25 Robinson James George Buy 40 000 Common Stock
INSIDER POWER
100.00
Last 2 transactions
Buy: 80 000 | Sell: 0

Forecast: 16:00 - $0.145

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $0.145 (-14.10% )
Volume 0.0026 mill
Avg. Vol. 0.0154 mill
% of Avg. Vol 16.78 %

Today

Intraday chart data with high, low, open and close for Allied Corp.

Last 12 Months

Last 12 months chart data with high, low, open and close for Allied Corp.

RSI

Last 10 Buy & Sell Signals For ALID

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Allied Corp.

ALID

Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

Last 10 Buy Signals

Date Signal @
UQCUSDMay 4 - 23:31$6.09
DPXUSDMay 4 - 23:3126.86
RNDRUSDMay 4 - 23:308.84
NEOUSDMay 4 - 23:30$16.45
DOTUSDMay 4 - 23:30$7.07
OHMUSDMay 4 - 23:2312.30
USDCUSDMay 4 - 23:03$0.999
TRIASUSDMay 4 - 23:039.21
GHSTUSDMay 4 - 23:04$1.810
IOTAUSDMay 4 - 23:010.224

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.